Physician profile
Ahmad R Namous
NPI 1578180584
$8,913.67
in general payments reported to CMS, 2019-2025
11 companies · $4,268 in 2025
The $4,268 reported for 2025 was more than what 89% of Sports Medicine (Podiatrist) providers received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $960 · 2021: $1,808 · 2022: $501 · 2023: $477 · 2024: $900 · 2025: $4,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,400 · Food and Beverage: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,400.14 |
| Food and Beverage | $2,244.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,826.90 | 2022-2025 | Hoffmann, Ortholoc 3di, Augment Injectable |
| Liberty Surgical INC. | $2,159.57 | 2020-2021 | |
| Paragon 28, INC. | $1,472.56 | 2025 | Portfolio |
| Smith+Nephew, INC. | $399.21 | 2021-2023 | Collagenase Santyl |
| Organogenesis INC. | $396.25 | 2021-2022 | |
| Integra Lifesciences Corporation | $360.26 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $115.46 | 2021 | |
| Osteomed LLC | $97.26 | 2022 | |
| Depuy Synthes Sales INC. | $39.30 | 2021 | |
| Heron Therapeutics, INC. | $24.26 | 2021 | |
| Next Science LLC | $22.64 | 2023 | Blastx, Xperience, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Namous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.